demonstrated that the tumor infiltrating lymphocytes (TIL) of metastatic lung tumors from patients with metastatic cholangiocarcinoma contain CD4+ T cells that recognize ERBB2IP mutations expressed in the tumor, and reactive CD4+ T cells are dominant. Here, CD4 is linked to neoplasm.